Literature DB >> 647775

Mechanism of electrical alternans in patients with pericardial effusion.

R L Rinkenberger, R A Polumbo, M R Bolton, M Dunn.   

Abstract

Electrical alternans concomitant with pericardial effusion has been considered a pathognomonic sign suggestive of a large effusion with cardiac tamponade, particularly if there is P wave alternans as well as QRS alternans. However, the mechanism of this phenomonon remains controversial. A patient with pericardial effusion secondary to adenocarcinoma of the lung with metastases, pericardial effusion, electrical alternans, and cardiac tamponade was studied by echocardiography, right and left heart catheterization, and pericardiocentesis. Hemodynamic data were consistent with cadiac tamponade. The echocardiogram demonstrated a large anterior and posterior pericardial effusion. Noncongruous motion of the septum and posterior wall was pericardial effusion. Noncongruous motion of the septum and posterior wall was recorded at a rate equal to the heart rate. In addition, congruous motion of the septum and posterior wall was recorded at a rate that was half the heart rate and corresponded to the electrical alternans. The congruous movement disappeared after pericardiocentesis, as did the electrical alternans. The electrical alternans is synchronous with and due to the pendulous movement of the heart within the pericardial sac, as demonstrated by echocardiogram and cineangiograms.

Entities:  

Mesh:

Year:  1978        PMID: 647775     DOI: 10.1002/ccd.1810040109

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  2 in total

1.  The importance of an ECG: back to basics.

Authors:  Golaleh Haidari; Kirsty Gray; Senthil Kirubakaran
Journal:  BMJ Case Rep       Date:  2012-11-28

2.  Paroxysmal Supraventricular Tachycardia with QRS Duration Alternans, Electrical Alternans, and Pulsus Alternans but without Cycle Length Alternans.

Authors:  Wei-Ta Chen; Ho-Shun Cheng; Jen-Hung Huang; Ming-Hsiung Hsieh
Journal:  Acta Cardiol Sin       Date:  2013-03       Impact factor: 2.672

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.